| Literature DB >> 25017102 |
Viviana Cordeddu1, Bert Redeker2, Emilia Stellacci3, Aldo Jongejan4, Alessandra Fragale5, Ted E J Bradley6, Massimiliano Anselmi7, Andrea Ciolfi3, Serena Cecchetti8, Valentina Muto3, Laura Bernardini9, Meron Azage10, Daniel R Carvalho11, Alberto J Espay12, Alison Male13, Anna-Maja Molin14, Renata Posmyk15, Carla Battisti16, Alberto Casertano17, Daniela Melis17, Antoine van Kampen4, Frank Baas6, Marcel M Mannens18, Gianfranco Bocchinfuso7, Lorenzo Stella7, Marco Tartaglia1, Raoul C Hennekam19.
Abstract
Primrose syndrome and 3q13.31 microdeletion syndrome are clinically related disorders characterized by tall stature, macrocephaly, intellectual disability, disturbed behavior and unusual facial features, with diabetes, deafness, progressive muscle wasting and ectopic calcifications specifically occurring in the former. We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome. This finding establishes a genetic link between these disorders and delineates the impact of ZBTB20 dysregulation on development, growth and metabolism.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25017102 DOI: 10.1038/ng.3035
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330